Differin Gel Enters Changed Marketplace Since Last OTC Acne Drug Approval
This article was originally published in The Pink Sheet
Executive Summary
Galderma Labs' adapalene gel is pending launch as first OTC acne ingredient approved through an NDA and first new acne ingredient available OTC in 20 years, but company must play in a digitally-oriented marketplace.
You may also be interested in...
Nestle Pairs Nutrition Science Business With Pharma Firm Making Peanut Allergy Treatment
Nestle agrees to acquire Aimmune Therapeutics, maker of a drug indicated to reduce the severity of children’s allergic reactions to peanuts. It anticipates options to innovate in its consumer health children’s allergy business.
Health And Wellness Market News: X Out Acne Line In GNC, Eosera In Rite Aid
Proactiv marketer Guthy Renker introduces X Out acne line in GNC stores; Eosera reaches Rite Aid, plans extensions; ANSI meeting discusses supply chain safety, standards; and Dr. Reddy’s launches Mucinex D equivalent.
At Nuvothera, Rx Derma Veterans Develop OTCs For Serious Skin Conditions
Firm launched Prosoria in 2018 as a four-product topical line for inflammatory autoimmune disease psoriasis containing salicylic acid 3% combined with turmeric and other botanicals. CEO Arthur Clapp says firm will launch turmeric supplements and plans adding products for acne, eczema, warts, nail fungus and rosacea.